Research Area: Viral sequence evolution

Primary: Shown in the list of current labels.

Year 2022

PubMed DOI Crossref

Robust humoral and cellular immune responses and low risk for reinfection at least 8 months following asymptomatic to mild COVID-19.

Havervall S, Ng H, Jernbom Falk A, ..., Hober S, Thålin C

J Intern Med 291 (1) 72-80 [2022-01-00; online 2021-09-27]

Category: Biochemistry Category: Health Funder: KAW/SciLifeLab National COVID program Research Area: Biobanks for COVID-19 research Research Area: Drug discovery and repurposing of drugs Research Area: High-throughput and high-content serology Research Area: Host cell systems biology and targets Research Area: Viral sequence evolution

Year 2021

PubMed DOI Crossref

COVseq is a cost-effective workflow for mass-scale SARS-CoV-2 genomic surveillance.

Simonetti M, Zhang N, Harbers L, ..., Ghisetti V, Crosetto N

Nat Commun 12 (1) 3903 [2021-06-23; online 2021-06-23]

Category: Biochemistry Category: Genomics & transcriptomics Category: Other Funder: KAW/SciLifeLab National COVID program Research Area: Viral sequence evolution Type: Journal article

PubMed DOI Crossref

Detection of SARS-CoV-2 using non-commercial RT-LAMP regents and raw samples.

Alekseenko A, Barrett D, Pareja-Sanchez Y, ..., Yin X, Pelechano V

Sci Rep 11 (1) 1820 [2021-01-21; online 2020-08-24]

Category: Other Funder: KAW/SciLifeLab National COVID program Funder: VR Research Area: Diagnostics for virus Research Area: Viral sequence evolution Type: Journal article